RxDoctor Payments Data

Shannah Wayne

Physician Assistant · Wilmington, NCNPI 1265022180

Payments from drug & device makers

$2,238in general payments, 2019–2025

Across 119 payments — averaging $18.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$222
  • Takeda Pharmaceuticals U.S.A., Inc.$114
  • Alnylam Pharmaceuticals Inc.$103
  • Gilead$85
  • Ardelyx, Inc.$83
  • plus $609 from 20 others

What the payments were for

  • Food & beverage$2,22399%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,238 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$30,676
Medicare patients
212
Services billed
339

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide40$36,651
LialdaMesalamine17$24,005
Dexlansoprazole DrDexlansoprazole69$20,507
TrulancePlecanatide16$13,857
Sucralfate12$4,072
Mesalamine18$3,263
Esomeprazole Magnesium68$2,402
Omeprazole167$2,216
Pantoprazole Sodium120$1,702
Lubiprostone13$1,045
Budesonide DrBudesonide17$950
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl51$921
Famotidine65$599
Dicyclomine Hcl49$519
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl19$340

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$1,022$36,65140 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$222$13,85716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Wilmington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →